Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13411545 | 0.84 | ALDH1A1 (0.53) | ALDH1A1L3MBTL1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL2968894 | 0.82 | MEN1 (0.63) | ALDH1A1L3MBTL1SMN1; SMN2MAPTCYP1A2 | |
| SCHEMBL12285735 | 0.80 | ALDH1A1 (0.60) | ALDH1A1L3MBTL1HPGDSMN1; SMN2MAPT | |
| SCHEMBL20878928 | 0.79 | LMNA (0.54) | ALDH1A1SMN1; SMN2GAAMEN1KMT2A | |
| SCHEMBL21861994 | 0.79 | ALDH1A1 (0.55) | ALDH1A1L3MBTL1HPGDSMN1; SMN2MAPT | |
| SCHEMBL15623097 | 0.78 | MEN1 (0.55) | ALDH1A1L3MBTL1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL20196302 | 0.78 | CA1 (0.51) | ALDH1A1L3MBTL1HPGDSMN1; SMN2MAPT | |
| SCHEMBL1755631 | 0.78 | MEN1 (0.55) | ALDH1A1L3MBTL1SMN1; SMN2MAPTMEN1 | |
| SCHEMBL19075835 | 0.78 | KMT2A (0.62) | ALDH1A1HPGDSMN1; SMN2MAPTGAA | |
| SCHEMBL132773 | 0.77 | ALDH1A1 (0.78) | ALDH1A1L3MBTL1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056507-A1 | PHENYL DERIVATIVES AND THEIR USE AS A MEDICAMENT | IPSEN PHARMA S.A.S. (FR) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056507-A1 | PHENYL DERIVATIVES AND THEIR USE AS A MEDICAMENT | CNR2, CNR1, TRPV1 | ALDH1A1 2439/4885L3MBTL1 4582/4885HPGD 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.